New Haven Biotech Goes Public and Execs Buy In With The Public

New Haven Biotech Goes Public and Execs Buy In With The Public

NEW HAVEN: A city biotech based on technology of Yale researcher Craig Crews has taken to the public markets with an Initial Public Offering on September 27. Arvinas, Inc . [Nasdaq: ARVN], the company's CEO, Chairman and other key executives have made significant stock purchases in the open market.

from Biotech News